A. Eden Evins, MD

Change in Cognition With Sustained Cannabis Abstinence

October 30, 2018

Regular cannabis use during adolescence has been linked to cognitive impairments. To what degree does abstaining from cannabis lead to cognitive improvements in adolescents and young adults who otherwise...

Randi Melissa Schuster, Jodi Gilman, David Schoenfeld, et al

Original Research

Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial

March 23, 2016

Anne N. Thorndike, Eric D. Achtyes, Corinne Cather, et al

Educational Activity

Does Using Marijuana Increase the Risk for Developing Schizophrenia?

April 15, 2013

A. Eden Evins, Alan I. Green, John M. Kane, et al

Article

The Effect of Marijuana Use on the Risk for Schizophrenia

November 15, 2012

A. Eden Evins, Alan I. Green, John M. Kane, et al

Article

Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use Disorders: A Meta-Analysis of Placebo-Controlled Randomized Trials

April 19, 2011

Nadia Iovieno, Enrico Tedeschini, Kate H. Bentley, et al

Original Research

Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia: A New Randomized Trial and a Meta-Analysis

April 5, 2011

Elaine Weiner, M. Patricia Ball, Alison S. Buchholz, et al

Original Research

Modafinil for Clozapine-Treated Schizophrenia Patients: A Double-Blind, Placebo-Controlled Pilot Trial

August 11, 2009

Oliver Freudenreich, David C. Henderson, Eric A. Macklin, et al

Original Research

Predictors of Early Abstinence in Smokers With Schizophrenia

November 30, 2008

Melissa A. Culhane, David A. Schoenfeld, Ruth S. Barr, et al

Letter to the Editor

Varenicline Treatment for Smokers With Schizophrenia: A Case Series

June 30, 2008

A. Eden Evins, Donald C. Goff

Article

A Randomized, Double-Blind, Placebo-Controlled Trial of Long-Acting Risperidone in Cocaine-Dependent Men

March 14, 2008

Tsafrir Loebl, Gustavo A. Angarita, Gladys N. Pachas, et al

Article

Commentary: Smoking Cessation in Patients With Psychiatric Disorders

February 14, 2008

Alan J. Gelenberg, Jose de Leon, A. Eden Evins, et al

Original Research

Smoking Cessation in Patients With Psychiatric Disorders

September 17, 2007

Alan J. Gelenberg, Jose de Leon, A. Eden Evins, et al

Change in Cognition With Sustained Cannabis Abstinence

Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial

Does Using Marijuana Increase the Risk for Developing Schizophrenia?

The Effect of Marijuana Use on the Risk for Schizophrenia

Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use Disorders: A Meta-Analysis of Placebo-Controlled Randomized Trials

Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia: A New Randomized Trial and a Meta-Analysis

Modafinil for Clozapine-Treated Schizophrenia Patients: A Double-Blind, Placebo-Controlled Pilot Trial

Predictors of Early Abstinence in Smokers With Schizophrenia

Varenicline Treatment for Smokers With Schizophrenia: A Case Series

A Randomized, Double-Blind, Placebo-Controlled Trial of Long-Acting Risperidone in Cocaine-Dependent Men

Commentary: Smoking Cessation in Patients With Psychiatric Disorders

Smoking Cessation in Patients With Psychiatric Disorders

ELSEWHERE:

FOLLOW US:

A. Eden Evins, MD

Change in Cognition With Sustained Cannabis Abstinence

Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial

Does Using Marijuana Increase the Risk for Developing Schizophrenia?

The Effect of Marijuana Use on the Risk for Schizophrenia

Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use Disorders: A Meta-Analysis of Placebo-Controlled Randomized Trials

Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia: A New Randomized Trial and a Meta-Analysis

Modafinil for Clozapine-Treated Schizophrenia Patients: A Double-Blind, Placebo-Controlled Pilot Trial

Predictors of Early Abstinence in Smokers With Schizophrenia

Varenicline Treatment for Smokers With Schizophrenia: A Case Series

A Randomized, Double-Blind, Placebo-Controlled Trial of Long-Acting Risperidone in Cocaine-Dependent Men

Commentary: Smoking Cessation in Patients With Psychiatric Disorders

Smoking Cessation in Patients With Psychiatric Disorders

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles